M
The startup develops bioidentical therapeutics aimed at reeducating dysregulated immune systems to facilitate functional tissue recovery. Their expertise spans therapeutic areas including infectious diseases and metabolic disorders, enabling clients to effectively manage inflammatory diseases and syndromes.
Besançon, FranceFounded 20171.4K
Updated 2 months ago
Funding
$750K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops bioidentical therapeutics aimed at reeducating dysregulated immune systems to facilitate functional tissue recovery. Their expertise spans therapeutic areas including infectious diseases and metabolic disorders, enabling clients to effectively manage inflammatory diseases and syndromes.